Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06343285 · ClinicalTrials.gov registry record · NA
Upper Limb Tremor Reduction in Essential Tremor Patients
A NA study, sponsored by Encora.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT06343285: Completed NA study, sponsored by Encora.
NCT06343285 is a NA study that has completed, run by Encora. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06343285, a NA study, has completed, sponsored by Encora.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
This study is designed to demonstrate the safety, tolerability, and efficacy of the Encora Therapeutics Tremor Mitigation Device in subjects with upper limb tremor caused by Essential Tremor.
Primary Outcome
The rate of subject-assessed comfort with stimulation, on a Subject Stimulation Tolerance Questionnaire as measured by % of patient who tolerated the treatment either none of the time, some of the time or all of the time.
Interventions
- DEVICE Encora Therapeutics Tremor Reduction Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2024-11-12 |
| Phase | NA |
What the finished NCT06343285 record still lists
NCT06343285 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Encora Therapeutics Tremor Reduction Device is the first listed.
NCT06343285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06343285 about?
NCT06343285 is a clinical study titled "Upper Limb Tremor Reduction in Essential Tremor Patients". This study is designed to demonstrate the safety, tolerability, and efficacy of the Encora Therapeutics Tremor Mitigation Device in subjects with upper limb tremor caused by Essential Tremor.
What is the current status of trial NCT06343285?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2024-01-01. Estimated completion is 2024-11-12.
What interventions are being tested in trial NCT06343285?
The interventions under investigation include: Encora Therapeutics Tremor Reduction Device (DEVICE).
Who is sponsoring clinical trial NCT06343285?
This trial is sponsored by Encora, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06343285's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI